)
Century Therapeutics (IPSC) investor relations material
Century Therapeutics Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Key program updates and pipeline progress
Advancing iPSC-derived cell therapies, including CAR T, CAR NK, and beta islet cells for autoimmune diseases, cancer, and type 1 diabetes.
Beta islet cell program (CNTY813) aims to treat type 1 diabetes with reduced or no chronic immunosuppression, targeting IND-enabling studies by year-end and IND submission as early as next year.
CD19 CAR-iT (CNTY-308) is set to enter clinical trials next year, focusing initially on autoimmune diseases with potential for reduced or no lymphodepletion.
Phase 1 Carmel study of CD19 CAR-NK (CNTY-101) in multiple autoimmune diseases is ongoing, with initial safety and translational data expected at an upcoming conference.
Discontinued Calypso study to focus resources on more promising programs and partnerships.
Scientific and technological innovations
Alloevasion 5.0 platform enables iPSC-derived cells to evade both cellular and humoral immune responses, using unique edits such as a universal NK cell inhibitory ligand and an IgG-degrading protease.
Preclinical studies show the IgG-degrading protease effectively eliminates antibody-mediated immune attack without systemic IgG depletion.
iPSC cell foundry allows direct differentiation into various cell types, supporting scalable and reproducible manufacturing.
Strategic focus and future directions
Emphasis on scalable manufacturing to address large patient populations in autoimmune diseases and type 1 diabetes.
Ongoing and potential future partnerships with pharma to expand access and leverage Alloevasion technology in new fields.
Exploring regenerative medicine applications beyond immune cell types, such as dopaminergic neurons for Parkinson’s and heart muscle cells for cardiac disease.
Next Century Therapeutics earnings date
Next Century Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage